APA (7th ed.) Citation

MP, C., AW, L., EO, H., ME, M., SI, G., SM, L., . . . NV, F. (2023). Clofarabine and Busulfan Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation for Patients With Active Myeloid Malignancies. Transplantation and cellular therapy, 29(2), 113. https://doi.org/10.1016/j.jtct.2022.10.027

Chicago Style (17th ed.) Citation

MP, Connor, et al. "Clofarabine and Busulfan Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation for Patients With Active Myeloid Malignancies." Transplantation and Cellular Therapy 29, no. 2 (2023): 113. https://doi.org/10.1016/j.jtct.2022.10.027.

MLA (9th ed.) Citation

MP, Connor, et al. "Clofarabine and Busulfan Myeloablative Conditioning in Allogeneic Hematopoietic Cell Transplantation for Patients With Active Myeloid Malignancies." Transplantation and Cellular Therapy, vol. 29, no. 2, 2023, p. 113, https://doi.org/10.1016/j.jtct.2022.10.027.